CUB buys Balter Beer
Carlton & United Breweries (CUB) has bought Gold Coast craft brewer, Balter Brewing Company for a confidential sum. Founded in 2016 by a group of friends including international surfer Mick Fanning, the brand joins other craft brews 4Pines and Pirate Life in the CUB stable. CUB is owned by Anheuser-Busch InBev.
Paint company fined over burnt worker
MMP Industrial has been fined a total of $75.750 and ordered to provide safety training to key staff after an industrial accident. A cleaning worker was seriously burnt while using flammable acetone – which combusted due to a static electric charge – to clean a mixing vat. According to SafeWork NSW, MMP committed two breaches of the Work Health and Safety Act 2011.
Optiscan appoints second China distributor
Microscopal imaging company Optiscan has appointed Biotimes Technology as distributor for its confocal surgical microscopes (pictured) in the Shanghai and eastern China regions. Biotimes is a leading distributor and was successful recently with the sale of Optiscan’s FIVE2 (ViewnVivo) microscope in a Chinese university tender.
PYC delivers drugs on target
PYC Therapeutics drug delivery technology, which targets drugs to particular cells, has proven effective in clinical trials. Its cell penetrating peptides proved effective in delivering large drug molecules to the layer of the retina susceptible to retinitis pigmentosa.
Orica posts key documents
Explosives and chemical group Orica has published its annual report, sustainability report and governance statement. Orica Managing Director Alberto Calderon said: “Our long-term investment in new technologies means we are leading our sector towards the possibilities of mining’s digital future, delivering sustainable growth and more value to our shareholders.”
Hair loss treatment sells
Life sciences company Cellmid (ASX: CDY) has generated $1.1 million in sales in its latest foray into sales on Japanese TV online shopping channel QVC. The company, which markets its Evolis product for reducing hair loss, will not incur shipping costs in its latest sale.
Borje Andersson joins Race Oncology
Professor Borje Andersson the developer of key drugs used in stem cell transplantation has joined the clinical advisory board of Race Oncology. Andersson, of the MD Anderson Cancer Centre in Houston joins Race, which is commercialising its Bisantrene treatment for acute myeloid leukaemia.
Subscribe to our free @AuManufacturing newsletter here.